Paul Tudor Jones Precigen, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Precigen, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 71,464 shares of PGEN stock, worth $100,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,464
Previous 71,464
-0.0%
Holding current value
$100,049
Previous $95,000
8.42%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PGEN
# of Institutions
141Shares Held
145MCall Options Held
208KPut Options Held
43.7K-
Third Security, LLC83.5MShares$117 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.5MShares$24.4 Million1.27% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$14.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.77MShares$9.48 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.03MShares$4.24 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $291M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...